AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
THE BURDEN OF MIGRAINE TO THE INDIVIDUAL SUFFERER - A REVIEW
Authors: DAHLOF CGH SOLOMON GD
Citation: Cgh. Dahlof et Gd. Solomon, THE BURDEN OF MIGRAINE TO THE INDIVIDUAL SUFFERER - A REVIEW, European journal of neurology, 5(6), 1998, pp. 525-533
QUALITY-OF-LIFE IN MIGRAINE
Authors: MANNIX LK SOLOMON GD
Citation: Lk. Mannix et Gd. Solomon, QUALITY-OF-LIFE IN MIGRAINE, Clinical neuroscience, 5(1), 1998, pp. 38-42
LONG-TERM PATIENT-REPORTED OUTCOMES IN A SPECIALTY HEADACHE CLINIC
Authors: MANNIX LK SOLOMON GD RYBICKI LA
Citation: Lk. Mannix et al., LONG-TERM PATIENT-REPORTED OUTCOMES IN A SPECIALTY HEADACHE CLINIC, Neurology, 50(4), 1998, pp. 5117-5117
DOSING OF ORAL SUMATRIPTAN - A REVIEW OF OUR FIRST 104 PATIENTS
Authors: SOLOMON GD FRIZELIS K BECKER J KUNKEL RS
Citation: Gd. Solomon et al., DOSING OF ORAL SUMATRIPTAN - A REVIEW OF OUR FIRST 104 PATIENTS, Headache, 38(5), 1998, pp. 349-351
POST GAMMA-KNIFE HEADACHE
Authors: LEE TG SKOBIERANDA FG SOLOMON GD
Citation: Tg. Lee et al., POST GAMMA-KNIFE HEADACHE, Headache, 38(1), 1998, pp. 59-59
THE IMPACT OF DRUG-THERAPY ON QUALITY-OF-LIFE IN HEADACHE AND MIGRAINE
Authors: SOLOMON GD LITAKER DG
Citation: Gd. Solomon et Dg. Litaker, THE IMPACT OF DRUG-THERAPY ON QUALITY-OF-LIFE IN HEADACHE AND MIGRAINE, PharmacoEconomics, 11(4), 1997, pp. 334-342
BURDEN OF MIGRAINE - A REVIEW OF ITS SOCIOECONOMIC IMPACT
Authors: SOLOMON GD PRICE KL
Citation: Gd. Solomon et Kl. Price, BURDEN OF MIGRAINE - A REVIEW OF ITS SOCIOECONOMIC IMPACT, PharmacoEconomics, 11, 1997, pp. 1-10
NATIONAL-HEADACHE-FOUNDATION - STANDARDS OF CARE FOR TREATING HEADACHE IN PRIMARY-CARE PRACTICE
Authors: SOLOMON GD CADY RK KLAPPER JA RYAN RE
Citation: Gd. Solomon et al., NATIONAL-HEADACHE-FOUNDATION - STANDARDS OF CARE FOR TREATING HEADACHE IN PRIMARY-CARE PRACTICE, Cleveland Clinic journal of medicine, 64(7), 1997, pp. 373-383
CLINICAL EFFICACY AND TOLERABILITY OF 2.5 MG ZOLMITRIPTAN FOR THE ACUTE TREATMENT OF MIGRAINE
Authors: SOLOMON GD CADY RK KLAPPER JA EARL NL SAPER JR RAMADAN NM
Citation: Gd. Solomon et al., CLINICAL EFFICACY AND TOLERABILITY OF 2.5 MG ZOLMITRIPTAN FOR THE ACUTE TREATMENT OF MIGRAINE, Neurology, 49(5), 1997, pp. 1219-1225
HEADACHE CLASSIFICATION
Authors: MANNIX LK SOLOMON GD KUNKEL RS
Citation: Lk. Mannix et al., HEADACHE CLASSIFICATION, Neurology, 49(2), 1997, pp. 638-639
EVOLUTION OF THE MEASUREMENT OF QUALITY-OF-LIFE IN MIGRAINE
Authors: SOLOMON GD
Citation: Gd. Solomon, EVOLUTION OF THE MEASUREMENT OF QUALITY-OF-LIFE IN MIGRAINE, Neurology, 48(3), 1997, pp. 10-15
2.5 MG 311C90 (ZOMIG, ZOLMITRIPTAN) IS CLINICALLY EFFECTIVE IN TREATING MIGRAINE - CLINICAL EFFICACY AND IMPROVEMENT IN ACTIVITY
Authors: SOLOMON GD CADY RK KLAPPER JA
Citation: Gd. Solomon et al., 2.5 MG 311C90 (ZOMIG, ZOLMITRIPTAN) IS CLINICALLY EFFECTIVE IN TREATING MIGRAINE - CLINICAL EFFICACY AND IMPROVEMENT IN ACTIVITY, Neurology, 48(3), 1997, pp. 1132-1132
ALCOHOL, SMOKING, AND CAFFEINE USE AMONG HEADACHE PATIENTS
Authors: MANNIX LK FRAME JR SOLOMON GD
Citation: Lk. Mannix et al., ALCOHOL, SMOKING, AND CAFFEINE USE AMONG HEADACHE PATIENTS, Headache, 37(9), 1997, pp. 572-576
USING PRETREATMENT QUALITY-OF-LIFE PERCEPTIONS TO PREDICT RESPONSE TOSUMATRIPTAN IN MIGRAINEURS
Authors: LITAKER DG SOLOMON GD GENZEN JR
Citation: Dg. Litaker et al., USING PRETREATMENT QUALITY-OF-LIFE PERCEPTIONS TO PREDICT RESPONSE TOSUMATRIPTAN IN MIGRAINEURS, Headache, 37(10), 1997, pp. 630-634
ADVANCES IN CLUSTER HEADACHE MANAGEMENT
Authors: LEWIS TA SOLOMON GD
Citation: Ta. Lewis et Gd. Solomon, ADVANCES IN CLUSTER HEADACHE MANAGEMENT, Cleveland Clinic journal of medicine, 63(4), 1996, pp. 237-244
REVERSIBLE CEREBELLAR PERFUSION IN FAMILIAL HEMIPLEGIC MIGRAINE
Authors: LEE TG SOLOMON GD KUNKEL RS RAJA S
Citation: Tg. Lee et al., REVERSIBLE CEREBELLAR PERFUSION IN FAMILIAL HEMIPLEGIC MIGRAINE, Lancet, 348(9038), 1996, pp. 1383-1383
COMPARISON OF GENERIC AND DISEASE-SPECIFIC QUALITY-OF-LIFE INSTRUMENTS IN PATIENTS WITH HEADACHE
Authors: MANNIX LK SOLOMON GD
Citation: Lk. Mannix et Gd. Solomon, COMPARISON OF GENERIC AND DISEASE-SPECIFIC QUALITY-OF-LIFE INSTRUMENTS IN PATIENTS WITH HEADACHE, Neurology, 46(2), 1996, pp. 4130-4130
USE OF CLINICAL-FEATURES TO PREDICT RESPONSE TO SUMATRIPTAN IN MIGRAINE
Authors: SOLOMON GD LITAKER DG GENZEN JR
Citation: Gd. Solomon et al., USE OF CLINICAL-FEATURES TO PREDICT RESPONSE TO SUMATRIPTAN IN MIGRAINE, Neurology, 46(2), 1996, pp. 4134-4134
IMPACT OF SUMATRIPTAN ON CLINIC UTILIZATION AND COSTS OF CARE IN MIGRAINEURS
Authors: LITAKER DG SOLOMON GD GENZEN JR
Citation: Dg. Litaker et al., IMPACT OF SUMATRIPTAN ON CLINIC UTILIZATION AND COSTS OF CARE IN MIGRAINEURS, Headache, 36(9), 1996, pp. 538-541
PREDICTING RESPONSE TO SUMATRIPTAN
Authors: SOLOMON GD GENZEN JR LITAKER DG
Citation: Gd. Solomon et al., PREDICTING RESPONSE TO SUMATRIPTAN, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 34-34
ADVANCES IN MIGRAINE MANAGEMENT
Authors: LEWIS TA SOLOMON GD
Citation: Ta. Lewis et Gd. Solomon, ADVANCES IN MIGRAINE MANAGEMENT, Cleveland Clinic journal of medicine, 62(3), 1995, pp. 148-155
QUALITY-OF-LIFE ASSESSMENT AMONG MIGRAINE PATIENTS TREATED WITH SUMATRIPTAN
Authors: SOLOMON GD SKOBIERANDA FG GENZEN JR
Citation: Gd. Solomon et al., QUALITY-OF-LIFE ASSESSMENT AMONG MIGRAINE PATIENTS TREATED WITH SUMATRIPTAN, Headache, 35(8), 1995, pp. 449-454
HYPERSENSITIVITY TO SUBSTANCE-P IN THE ETIOLOGY OF POSTLUMBAR PUNCTURE HEADACHE
Authors: SOLOMON GD CLARK JW DESENANAYAKE P KUNKEL RS
Citation: Gd. Solomon et al., HYPERSENSITIVITY TO SUBSTANCE-P IN THE ETIOLOGY OF POSTLUMBAR PUNCTURE HEADACHE, Headache, 35(1), 1995, pp. 25-28
CHRONIC TENSION-TYPE HEADACHE - DEPRESSION AND THERAPY
Authors: MANNIX L SOLOMON GD
Citation: L. Mannix et Gd. Solomon, CHRONIC TENSION-TYPE HEADACHE - DEPRESSION AND THERAPY, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 202-202
USE OF A 9-ITEM PAIN SURVEY TO MEASURE THE IMPACT OF SUMATRIPTAN ON QUALITY-OF-LIFE IN MIGRAINE PATIENTS
Authors: SKOBIERANDA FG SOLOMON GD GENZEN JR
Citation: Fg. Skobieranda et al., USE OF A 9-ITEM PAIN SURVEY TO MEASURE THE IMPACT OF SUMATRIPTAN ON QUALITY-OF-LIFE IN MIGRAINE PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 202-202
Risultati: 1-25 | 26-33